MedTrace Logo

Prognostic Factors for Complex Regional Pain Syndrome

NCT05337501 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2024-05-01

No results posted yet for this study

Summary

The investigators would like to examine the role of some relevant biopsychosocial factors in the development of persistent CRPS. According to the International Classification of Functioning, Disability and Health (ICF) \[43\], the outcomes will belong to one of the three following components:

* Body structures and functions (pain, CRPS severity score (CSS)),
* Activities (disability)
* Participation (return to work, quality of life). The primary aim is to assess predicting factors for chronification.

The secondary aims are:

* to evaluate if it is possible to classify acute complex regional pain syndrome (CRPS) patients into subgroups according to their risk of chronification.
* to document the course of the disease. The main evaluation criteria will be to determine the impact of the different clinical and non-clinical variables on the course of the CRPS and on the aforementioned outcomes then, which will use as endpoints.
* Primary endpoint: disability
* Secondary endpoints: participation-QoL, return to work, pain, CRPS severity score.

Conditions

  • Complex Regional Pain Syndromes

Interventions

OTHER

Collecting data

Anamnesis, clinical examination, Quantitative Sensory Testing (following DFNS, German Research Network on Neuropathic Pain, protocol), visual TOJ (Temporal Order Judgement) task

Sponsors & Collaborators

  • Université Catholique de Louvain

    collaborator OTHER

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Anne Berquin, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-28
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05337501 on ClinicalTrials.gov